Hormonal changes in the first 24 postoperative hours after cardiac surgical procedures.


Journal

Physiology international
ISSN: 2498-602X
Titre abrégé: Physiol Int
Pays: Hungary
ID NLM: 101696724

Informations de publication

Date de publication:
05 Sep 2023
Historique:
received: 03 04 2023
revised: 23 06 2023
accepted: 01 07 2023
medline: 6 9 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

Hormone level changes after heart surgeries are a widely observed phenomenon due to neurohormonal feedback mechanisms that may affect postoperative morbidity and mortality. The current study aimed to analyze the changes in thyroid and sex hormones in the first 24 postoperative hours after heart surgery. This prospective, observational study (registered on ClinicalTrials.gov: NCT03736499; 09/11/2018) included 49 patients who underwent elective cardiac surgical procedures at a tertiary heart center between March 2019 and December 2019. Thyroid hormones, including thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4), and sex hormones, including prolactin (PRL) and total testosterone, were measured preoperatively and at 24 h postoperatively. Significant decreases in serum TSH (P < 0.001), T3 (P < 0.001) and total testosterone (P < 0.001) levels were noted, whereas T4 (P = 0.554) and PRL (P = 0.616) did not significantly change. Intensive care unit (ICU) hours (P < 0.001), mechanical ventilation (P < 0.001) and Vasoactive-Inotropic Score (VIS) (P = 0.006) were associated with postoperative T3 level. ICU hours were associated with postoperative T4 level (P = 0.028). Postoperative and delta testosterone levels were in connection with lengths of stay in ICU (P = 0.032, P = 0.010 respectively). Model for End-Stage Liver Disease (MELD) scores were associated with thyroid hormone levels and serum testosterone. T3 may represent a marker of nonthyroidal illness syndrome and testosterone may reflect hepatic dysfunction. In addition, PRL may act as a stress hormone in female patients.

Sections du résumé

Background UNASSIGNED
Hormone level changes after heart surgeries are a widely observed phenomenon due to neurohormonal feedback mechanisms that may affect postoperative morbidity and mortality. The current study aimed to analyze the changes in thyroid and sex hormones in the first 24 postoperative hours after heart surgery.
Methods UNASSIGNED
This prospective, observational study (registered on ClinicalTrials.gov: NCT03736499; 09/11/2018) included 49 patients who underwent elective cardiac surgical procedures at a tertiary heart center between March 2019 and December 2019. Thyroid hormones, including thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4), and sex hormones, including prolactin (PRL) and total testosterone, were measured preoperatively and at 24 h postoperatively.
Results UNASSIGNED
Significant decreases in serum TSH (P < 0.001), T3 (P < 0.001) and total testosterone (P < 0.001) levels were noted, whereas T4 (P = 0.554) and PRL (P = 0.616) did not significantly change. Intensive care unit (ICU) hours (P < 0.001), mechanical ventilation (P < 0.001) and Vasoactive-Inotropic Score (VIS) (P = 0.006) were associated with postoperative T3 level. ICU hours were associated with postoperative T4 level (P = 0.028). Postoperative and delta testosterone levels were in connection with lengths of stay in ICU (P = 0.032, P = 0.010 respectively). Model for End-Stage Liver Disease (MELD) scores were associated with thyroid hormone levels and serum testosterone.
Conclusions UNASSIGNED
T3 may represent a marker of nonthyroidal illness syndrome and testosterone may reflect hepatic dysfunction. In addition, PRL may act as a stress hormone in female patients.

Identifiants

pubmed: 37540593
doi: 10.1556/2060.2023.00219
doi:

Substances chimiques

Thyroid Hormones 0
Thyrotropin 9002-71-5
Testosterone 3XMK78S47O

Banques de données

ClinicalTrials.gov
['NCT03736499']

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-266

Auteurs

Balázs Szécsi (B)

1Doctoral School of Theoretical and Translational Medicine, Semmelweis University, Budapest, Hungary.

Krisztina Tóth (K)

1Doctoral School of Theoretical and Translational Medicine, Semmelweis University, Budapest, Hungary.

András Szabó (A)

2Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.

Csaba Eke (C)

1Doctoral School of Theoretical and Translational Medicine, Semmelweis University, Budapest, Hungary.

Rita Szentgróti (R)

1Doctoral School of Theoretical and Translational Medicine, Semmelweis University, Budapest, Hungary.

Orsolya Dohán (O)

3Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.

Kálmán Benke (K)

4Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Tamás Radovits (T)

4Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Miklós Pólos (M)

4Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Béla Merkely (B)

4Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

János Gál (J)

2Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.

Andrea Székely (A)

2Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.
5Department of Oxiology and Emergency Care, Semmelweis University, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH